Physician profile
Michael R Cook
NPI 1073597027
$1,002.66
in general payments reported to CMS, 2019-2025
12 companies · $57.59 in 2025
The $57.59 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $32.33 · 2021: $104 · 2022: $184 · 2023: $192 · 2024: $140 · 2025: $57.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $484.51 | 2019-2024 | Puraply Am, Puraply |
| Advanced Oxygen Therapy INC. | $147.26 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $91.09 | 2020-2025 | Collagenase Santyl |
| Kci USA, INC. | $88.37 | 2019-2023 | V.A.C. Dermatac, Activ.A.C., Promogran Prisma |
| Medtronic, INC. | $43.29 | 2024 | |
| Misonix INC | $37.54 | 2021 | |
| Next Science LLC | $33.91 | 2023 | Blastx, Xperience, Surgx |
| Mimedx Group, INC. | $19.04 | 2025 | |
| Solventum Corporation | $15.39 | 2024 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
| Ovik Health, LLC | $15.05 | 2021 | |
| Integra Lifesciences Corporation | $13.96 | 2019 | |
| Cashflow Solutions, LLC | $13.25 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.